30 Oct 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/10/30/2971630/0/en/Noema-Pharma-Announces-First-Patients-Dosed-in-Phase-2b-Study-with-Gemlapodect-NOE-105-a-First-In-Class-Investigational-Therapy-for-Tourette-Syndrome.html
LOOKING FOR A SUPPLIER?